Oncology
 |
|
8 april 2021 00:39:17 |
| Correction to: RGD4C peptide mediates anti-p21Ras scFv entry into tumor cells and produces an inhibitory effect on the human colon cancer cell line SW480 (BMC Cancer) |
|
Tweet An amendment to this paper has been published and can be accessed via the original article. |
| 176 viewsCategory: Oncology |
 Risk factors for pegylated liposomal doxorubicin-induced moderate to severe hand-foot syndrome in breast cancer patients: assessment of baseline clinical parameters (BMC Cancer)Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers (BMC Cancer) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
